BioNTech SE (BNTX) Assets Average (2019 - 2026)

BioNTech SE has reported Assets Average for 7 years, with the latest figure at $25.3 billion in Q4 2025.

• Quarterly Assets Average rose 3.84% year-over-year to $25.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 billion (up 3.84% YoY) and the FY2025 annual result came in at $24.5 billion, changed 0.18% from the prior year.
• Assets Average rose to $25.3 billion in Q4 2025 per BNTX's latest filing, from $24.7 billion in the prior quarter.
• Over five years, Assets Average peaked at $25.3 billion in Q4 2025 and troughed at $3.9 billion in Q1 2021.
• A 5-year average of $21.1 billion and a median of $23.6 billion in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2025: Assets Average surged 905.48% in 2021, then retreated 5.26% in 2025.
• Over 5 years, Assets Average stood at $17.4 billion in 2021, then soared by 33.54% to $23.3 billion in 2022, then climbed by 5.0% to $24.5 billion in 2023, then fell by 0.51% to $24.3 billion in 2024, then climbed by 3.84% to $25.3 billion in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $25.3 billion, $24.7 billion, and $23.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.